Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

eNOS T-786C polymorphism affects atorvastatin-induced changes in erythrocyte membrane fluidity (2009)

  • Authors:
  • USP affiliated authors: SANTOS, JOSE EDUARDO TANUS DOS - FMRP
  • USP Schools: FMRP
  • DOI: 10.1007/s00228-008-0602-7
  • Subjects: GENÓTIPOS; POLIMORFISMO; ÓXIDO NÍTRICO; CÉLULAS SANGUÍNEAS
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    DOI or search this record in
    Informações sobre o DOI: 10.1007/s00228-008-0602-7 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Informações sobre o Citescore
  • Título: DNA and Cell Biology

    ISSN: 1044-5498

    Citescore - 2017: 2.31

    SJR - 2017: 0.872

    SNIP - 2017: 0.693


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FMRP1806681pcd 1806681
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      NAGASSAKI, S.; HERCULANO, R. D.; GRAEFF, Carlos Frederico de Oliveira; TANUS-SANTOS, José Eduardo. eNOS T-786C polymorphism affects atorvastatin-induced changes in erythrocyte membrane fluidity. , Berlin, 2009. DOI: 10.1007/s00228-008-0602-7.
    • APA

      Nagassaki, S., Herculano, R. D., Graeff, C. F. de O., & Tanus-Santos, J. E. (2009). eNOS T-786C polymorphism affects atorvastatin-induced changes in erythrocyte membrane fluidity. doi:10.1007/s00228-008-0602-7
    • NLM

      Nagassaki S, Herculano RD, Graeff CF de O, Tanus-Santos JE. eNOS T-786C polymorphism affects atorvastatin-induced changes in erythrocyte membrane fluidity. 2009 ;
    • Vancouver

      Nagassaki S, Herculano RD, Graeff CF de O, Tanus-Santos JE. eNOS T-786C polymorphism affects atorvastatin-induced changes in erythrocyte membrane fluidity. 2009 ;

    Referências citadas na obra
    Lubin B, Kuypers F, Chiu D (1989) Red cell membrane lipid dynamics. Prog Clin Biol Res 319:507–522; discussion 523–504
    Dougherty RM, Galli C, Ferro-Luzzi A, Iacono JM (1987) Lipid and phospholipid fatty acid composition of plasma, red blood cells, and platelets and how they are affected by dietary lipids: a study of normal subjects from Italy, Finland, and the USA. Am J Clin Nutr 45:443–455
    Macchia T, Mancinelli R, Barbini DA, Taggi F, Avico U, Cantafora A (1991) Determination of membrane cholesterol in normal and pathological red blood cells. Clin Chim Acta 199:59–67
    Ozdemirler G, Kucuk S, Orhan Y, Aykac-Toker G, Uysal M (2001) Lipid and protein oxidation in erythrocyte membranes of hypercholesterolemic subjects. Clin Biochem 34:335–339
    Koter M, Franiak I, Strychalska K, Broncel M, Chojnowska-Jezierska J (2004) Damage to the structure of erythrocyte plasma membranes in patients with type-2 hypercholesterolemia. Int J Biochem Cell Biol 36:205–215
    Mawatari S, Ohnishi Y, Kaji Y, Maruyama T, Murakami K, Tsutsui K, Fujino T (2003) High-cholesterol diets induce changes in lipid composition of rat erythrocyte membrane including decrease in cholesterol, increase in alpha-tocopherol and changes in fatty acids of phospholipids. Biosci Biotechnol Biochem 67:1457–1464
    Canessa M, Adragna N, Solomon HS, Connolly TM, Tosteson DC (1980) Increased sodium-lithium countertransport in red cells of patients with essential hypertension. N Engl J Med 302:772–776
    Zerbini G, Ceolotto G, Gaboury C, Mos L, Pessina AC, Canessa M, Semplicini A (1995) Sodium-lithium countertransport has low affinity for sodium in hyperinsulinemic hypertensive subjects. Hypertension 25:986–993
    Yamori Y, Nara Y, Horie R, Ooshima A (1980) Abnormal membrane characteristics of erythrocytes in rat models and men with predisposition to stroke. Clin Exp Hypertens 2:1009–1021
    Muriel P, Sandoval G (2000) Nitric oxide and peroxynitrite anion modulate liver plasma membrane fluidity and Na(+)/K(+)-ATPase activity. Nitric Oxide 4:333–342
    Tsuda K, Kimura K, Nishio I, Masuyama Y (2000) Nitric oxide improves membrane fluidity of erythrocytes in essential hypertension: An electron paramagnetic resonance investigation. Biochem Biophys Res Commun 275:946–954
    Tsuda K, Nishio I (2004) A calcium channel blocker, benidipine, improves cell membrane fluidity in human subjects via a nitric oxide-dependent mechanism. An electron paramagnetic resonance investigation. Am J Hypertens 17:1143–1150
    Gaffney BJ, McNamee CM (1974) Spin-label measurements in membranes. With appendix: a use of computers in EPR spectroscopy. Methods Enzymol 32:161–198
    Wierzbicki AS, Poston R, Ferro A (2003) The lipid and non-lipid effects of statins. Pharmacol Ther 99:95–112
    Palinski W (2001) New evidence for beneficial effects of statins unrelated to lipid lowering. Arterioscler Thromb Vasc Biol 21:3–5
    Takemoto M, Liao JK (2001) Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler Thromb Vasc Biol 21:1712–1719
    Dilaveris P, Giannopoulos G, Riga M, Synetos A, Stefanadis C (2007) Beneficial effects of statins on endothelial dysfunction and vascular stiffness. Curr Vasc Pharmacol 5:227–237
    Delliaux S, Steinberg JG, Bechis G, Paganelli F, Oliver C, Lesavre N, Jammes Y (2007) Statins alter oxidant-antioxidant status and lower exercise-induced oxidative stress. Int J Clin Pharmacol Ther 45:244–252
    Liao JK, Laufs U (2005) Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 45:89–118
    Martinez M, Vaya A, Marti R, Gil L, Lluch I, Carmena R, Aznar J (1996) Effect of HMG-CoA reductase inhibitors on red blood cell membrane lipids and haemorheological parameters, in patients affected by familial hypercholesterolemia. Haemostasis 26[Suppl 4]:171–176
    Nagassaki S, Sertorio JT, Metzger IF, Bem AF, Rocha JB, Tanus-Santos JE (2006) eNOS gene T-786C polymorphism modulates atorvastatin-induced increase in blood nitrite. Free Radic Biol Med 41:1044–1049
    Fatini C, Mannini L, Sticchi E, Cecchi E, Bruschettini A, Leprini E, Pagnini P, Gensini GF, Prisco D, Abbate R (2005) eNOS gene affects red cell deformability: role of T-786C, G894T, and 4a/4b polymorphisms. Clin Appl Thromb Hemost 11:481–488
    Souza-Costa DC, Sandrim VC, Lopes LF, Gerlach RF, Rego EM, Tanus-Santos JE (2007) Anti-inflammatory effects of atorvastatin: modulation by the T-786C polymorphism in the endothelial nitric oxide synthase gene. Atherosclerosis 193:438–444
    Tanus-Santos JE, Desai M, Flockhart DA (2001) Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics 11:719–725
    Nagassaki S, Metzger IF, Souza-Costa DC, Marroni AS, Uzuelli JA, Tanus-Santos JE (2005) eNOS genotype is without effect on circulating nitrite/nitrate level in healthy male population. Thromb Res 115:375–379
    Marroni AS, Metzger IF, Souza-Costa DC, Nagassaki S, Sandrim VC, Correa RX, Rios-Santos F, Tanus-Santos JE (2005) Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase genetic polymorphisms. Nitric Oxide 12:177–182
    Tanus-Santos JE, Desai M, Deak LR, Pezzullo JC, Abernethy DR, Flockhart DA, Freedman JE (2002) Effects of endothelial nitric oxide synthase gene polymorphisms on platelet function, nitric oxide release, and interactions with estradiol. Pharmacogenetics 12:407–413
    Dodge JT, Mitchell C, Hanahan DJ (1963) The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Arch Biochem Biophys 100:119–130
    Rodriguez-Vico F, Martinez-Cayuela M, Zafra MF, Garcia-Peregrin E, Ramirez H (1991) A procedure for the simultaneous determination of lipid and protein in biomembranes and other biological samples. Lipids 26:77–80
    Schreier-Muccillo S, Marsh D, Smith IC (1976) Monitoring the permeability profile of lipid membranes with spin probes. Arch Biochem Biophys 172:1–11
    Schreier S, Polnaszek CF, Smith IC (1978) Spin labels in membranes. Problems in practice. Biochim Biophys Acta 515:395–436
    Koter M, Broncel M, Chojnowska-Jezierska J, Klikczynska K, Franiak I (2002) The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia. Eur J Clin Pharmacol 58:501–506
    Koter M, Franiak I, Broncel M, Chojnowska-Jezierska J (2003) Effects of simvastatin and pravastatin on peroxidation of erythrocyte plasma membrane lipids in patients with type 2 hypercholesterolemia. Can J Physiol Pharmacol 81:485–492
    Rabini RA, Polenta M, Staffolani R, Tocchini M, Signore R, Testa I, Mazzanti L (1993) Effect of hydroxymethylglutaryl-CoA reductase inhibitors on the functional properties of erythrocyte membranes. Exp Mol Pathol 59:51–57
    Jubelin BC, Gierman JL (1996) Erythrocytes may synthesize their own nitric oxide. Am J Hypertens 9:1214–1219
    Kleinbongard P, Schulz R, Rassaf T, Lauer T, Dejam A, Jax T, Kumara I, Gharini P, Kabanova S, Ozuyaman B, Schnurch HG, Godecke A, Weber AA, Robenek M, Robenek H, Bloch W, Rosen P, Kelm M (2006) Red blood cells express a functional endothelial nitric oxide synthase. Blood 107:2943–2951
    Laufs U, La Fata V, Plutzky J, Liao JK (1998) Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97:1129–1135
    Laufs U, Gertz K, Huang P, Nickenig G, Bohm M, Dirnagl U, Endres M (2000) Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice. Stroke 31:2442–2449
    Laufs U, Wassmann S, Hilgers S, Ribaudo N, Bohm M, Nickenig G (2001) Rapid effects on vascular function after initiation and withdrawal of atorvastatin in healthy, normocholesterolemic men. Am J Cardiol 88:1306–1307
    Pintaric I, Eterovic D, Tocilj J, Reiner Z, Lusic I (2001) Effect of simvastatin on micropulmonary red cell mass in patients with hyperlipoproteinemia. Atherosclerosis 154:493–496
    Martinez M, Vaya A, Marti R, Gil L, Lluch I, Carmena R, Aznar J (1996) Erythrocyte membrane cholesterol/phospholipid changes and hemorheological modifications in familial hypercholesterolemia treated with lovastatin. Thromb Res 83:375–388